Pharmafile Logo

Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview

December 11, 2025 |  

At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright’s HEOR Theater presentation ‘MFN Pricing: More Fun to Navigate – A European Roadmap to Success,’ with potentially over a hundred individuals missing out on the chance to learn more about how to prepare for most-favored nation pricing.

Due to its popularity and the ever-changing nature of this vital topic, Genesis Research Group has teamed up with The Evidence Base to review and update the presentation in the light of recent developments.

MFN pricing presentation advert

During the original presentation, Tim Wright, EVP, Access & Pricing at Genesis Research Group, outlined a practical roadmap for navigating MFN pricing, from establishing a U.S. anchor price and applying value-based approaches to mitigating European price erosion risks. The session offered valuable insights for market access professionals seeking to balance policy pressures with innovative pricing strategies.

In a newly recorded interview with The Evidence Base, Tim presents an updated version of his presentation plus commentary on the latest most-favored nation pricing developments. Tim breaks down:

– A recap of the original session: “MFN Pricing: ‘More Fun to Navigate’ – A European Roadmap to Success”
– The GENEROUS Model in relation to MFN
– How MFN and the IRA differ—and where they intersect
– Advice and practical steps to prepare for MFN activities

To access this timely resource for pricing, market access, and HEOR professionals navigating rapidly shifting policy landscapes, visit The Evidence Base.

If you have questions or would like a meeting to discuss, you can contact Tim via solutions@genesisrg.com.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research Acquires Market Access Transformation

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

GHO Capital Acquires Genesis Research

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

Genesis Research: What is EVID AI?

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches